TILT-452

N/A

Report date: 2023/10/26 16:48:36

Base Information

Drug NameTILT-452
Drug Alias NameTILT-452Ad5/3-E2F-d24-vIL2
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionInterleukin-2 stimulantsTumor necrosis factor α stimulantsCell death stimulants +[4] 
TargetsInterleukin-2Tumor necrosis factor α
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTilt Biotherapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTilt Biotherapeutics Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A